What drove the 13.33% drop in 1EZ0.F stock on 13 Jan 2026?

The fall reflected thin liquidity, negative earnings (EPS **-88.61**), and weak cash flows. Volume spiked to **5,628** against an average of **3,567**, which magnified selling pressure on XETRA.

What is Meyka AI's view on 1EZ0.F stock?

Meyka AI rates 1EZ0.F at **66.50** out of 100 (Grade **B**, Suggestion: HOLD). The model flags liquidity and valuation risk and projects a 12-month price of **€0.05**. Projections are not guarantees.

What are key support and resistance levels for 1EZ0.F stock?

Immediate support sits near the session low **€0.13**. Near-term resistance is **€0.18** and Bollinger middle at **€0.25**. The 50-day average of **€0.37** is a higher, longer-term resistance.

Should investors buy 1EZ0.F stock after the drop?

Given negative EPS, weak cash flow, and thin liquidity, buying is high risk. Wait for consistent operational improvements, cash flow recovery, or clearer capital structure before adding a meaningful position.

DE Stocks

Europlasma (1EZ0.F XETRA) down 13.33% 13 Jan 2026: liquidity, valuation risks

ByHuzaifa Zahoor January 14, 2026

1EZ0.F stock closed sharply lower on XETRA on 13 Jan 2026, falling 13.33% to €0.13. Volume was 5,628 shares versus an average of 3,567, highlighting thin liquidity that amplified the decline. Intraday high was €0.18 and the session low was €0.13, leaving intraday range tight near the year low. Traders cited weak fundamentals, negative cash flows, and negative EPS of -88.61 as drivers. We examine price action, fundamentals, technicals, and the Meyka AI forecast to frame downside risk and short-term trade setups on the Germany XETRA market.